Published in Cancer Weekly, May 1st, 2006
"FDG-PET and CT are widely accepted in the evaluation for metastatic or recurrent rectal cancer. Only spiral CT and transrectal ultrasonography (TRUS) are routinely used in the initial evaluation of primary rectal cancer," scientists in the United States reported.
"We wished to determine whether PET/CT could provide additional information in patients undergoing standard evaluation for primary rectal cancer. Thirty-seven patients (mean age, 58 years; range, 26-90 years) with a previously untreated rectal cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.